-
Something wrong with this record ?
Prediction Score for persisting perfusion defects after pulmonary embolism
J. Mrozek, T. Necasova, M. Svoboda, I. Simkova, P. Jansa
Language English Country Czech Republic
Document type Comparative Study, Journal Article
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
Medline Complete (EBSCOhost)
from 2007-06-01
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
31551608
DOI
10.5507/bp.2019.033
Knihovny.cz E-resources
- MeSH
- Anticoagulants therapeutic use MeSH
- Adult MeSH
- Echocardiography MeSH
- Hemoglobins analysis MeSH
- Middle Aged MeSH
- Humans MeSH
- Pulmonary Embolism complications drug therapy MeSH
- Hypertension, Pulmonary drug therapy etiology MeSH
- Clinical Decision Rules * MeSH
- Proportional Hazards Models MeSH
- Risk Factors MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Age Factors MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged, 80 and over MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Comparative Study MeSH
AIMS: Long-term persistence of perfusion defect after pulmonaryembolism (PE) may lead to the development of chronic thromboembolic pulmonary hypertension. Identification of patients at risk of such a complication using a scoring system would be beneficial in clinical practice. Here, we aimed to derive a score for predicting persistence of perfusion defects after PE. METHODS: 83 patients after PE were re-examined 6, 12 and 24 months after the PE episode. Data collected at the time of PE and perfusion status during follow-ups were used for modelling perfusion defects persistence using the Cox proportional hazards model and validated using bootstrap method. RESULTS: A simple scoring system utilizing two variables (hemoglobin levels and age at the time of PE) was developed. Patients with hemoglobin levels over 140 g/L who were older than 65 years were at the highest risk of perfusion defects; in patients with the same hemoglobin levels and age <65 years, the risk was reduced by 79%, and by 89% in patients with hemoglobin <140 g/L. CONCLUSION: The proposed scoring system may be useful in clinical practice for identifying patients with high risk of persisting perfusion defects, flagging them for closer follow up, thus improving the effectiveness of long-term treatment of patients after PE.
References provided by Crossref.org
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc21023717
- 003
- CZ-PrNML
- 005
- 20211116103907.0
- 007
- ta
- 008
- 211005s2020 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2019.033 $2 doi
- 035 __
- $a (PubMed)31551608
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Mrózek, Jan, $d 1976- $7 xx0242199 $u Department of Cardiovascular Diseases, University Hospital Ostrava, 17. listopadu 1790, 708 52 Ostrava-Poruba, Czech Republic
- 245 10
- $a Prediction Score for persisting perfusion defects after pulmonary embolism / $c J. Mrozek, T. Necasova, M. Svoboda, I. Simkova, P. Jansa
- 504 __
- $a Literatura
- 520 9_
- $a AIMS: Long-term persistence of perfusion defect after pulmonaryembolism (PE) may lead to the development of chronic thromboembolic pulmonary hypertension. Identification of patients at risk of such a complication using a scoring system would be beneficial in clinical practice. Here, we aimed to derive a score for predicting persistence of perfusion defects after PE. METHODS: 83 patients after PE were re-examined 6, 12 and 24 months after the PE episode. Data collected at the time of PE and perfusion status during follow-ups were used for modelling perfusion defects persistence using the Cox proportional hazards model and validated using bootstrap method. RESULTS: A simple scoring system utilizing two variables (hemoglobin levels and age at the time of PE) was developed. Patients with hemoglobin levels over 140 g/L who were older than 65 years were at the highest risk of perfusion defects; in patients with the same hemoglobin levels and age <65 years, the risk was reduced by 79%, and by 89% in patients with hemoglobin <140 g/L. CONCLUSION: The proposed scoring system may be useful in clinical practice for identifying patients with high risk of persisting perfusion defects, flagging them for closer follow up, thus improving the effectiveness of long-term treatment of patients after PE.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a věkové faktory $7 D000367
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a senioři nad 80 let $7 D000369
- 650 _2
- $a antikoagulancia $x terapeutické užití $7 D000925
- 650 12
- $a pravidla klinického rozhodování $7 D000081415
- 650 _2
- $a echokardiografie $7 D004452
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a hemoglobiny $x analýza $7 D006454
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a plicní hypertenze $x farmakoterapie $x etiologie $7 D006976
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a proporcionální rizikové modely $7 D016016
- 650 _2
- $a plicní embolie $x komplikace $x farmakoterapie $7 D011655
- 650 _2
- $a rizikové faktory $7 D012307
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Nečasová, Tereza, $d 1992- $7 mub2017943671 $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University Brno, Postovska 68/3, 602 00 Brno, Czech Republic
- 700 1_
- $a Svoboda, Michal $7 xx0230935 $u Institute of Biostatistics and Analyses, Faculty of Medicine, Masaryk University Brno, Postovska 68/3, 602 00 Brno, Czech Republic
- 700 1_
- $a Šimková, Iveta $7 jx20120222045 $u National Institute of Cardiovascular Diseases and Slovak Medical University, Pod Krasnou horkou 7185/1, 831 01 Bratislava - Nove Mesto, Slovak Republic
- 700 1_
- $a Jansa, Pavel, $d 1971- $7 jo2008427138 $u Clinical Department of Cardiology and Angiology, 1st Faculty of Medicine, 2nd Medical Department, Charles University, U Nemocnice 499/2, 128 08 Praha 2 - Nove Mesto, Czech Republic
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia $x 1213-8118 $g Roč. 164, č. 4 (2020), s. 394-400
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/31551608 $y Pubmed
- 910 __
- $a ABA008 $b A 1502 $c 958 $y p $z 0
- 990 __
- $a 20211005 $b ABA008
- 991 __
- $a 20211116103908 $b ABA008
- 999 __
- $a ok $b bmc $g 1718905 $s 1144211
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 164 $c 4 $d 394-400 $e 20190913 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK118 $a Pubmed-20211005